Psoriasis Exacerbation Following Dupilumab Use In A Nine-year-old Black Male Patient

Distinguishing between psoriasis and other inflammatory dermatoses in pediatric skin of color can pose challenges. As more topical and systemic treatments become available for pediatric patients, early and accurate diagnoses are needed to help guide treatments for those that progress to severe disease. Delays in diagnosis for this population often lead to worsening disease until a correct diagnosis is reached. The goal of this article is to improve the understanding of inflammatory dermatoses in skin of color and review differential diagnoses, by presenting a case of psoriasis in a pediatric patient who flared after receiving dupilumab for an incorrect diagnosis of atopic dermatitis.